Publication | Closed Access
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
267
Citations
15
References
2022
Year
In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1-3 years of treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1